585 related articles for article (PubMed ID: 27701713)
1. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
[TBL] [Abstract][Full Text] [Related]
2. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
Ruiz ME; Gantner ME; Talevi A
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
[TBL] [Abstract][Full Text] [Related]
3. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
Zhang J; Tang H; Liu Z; Chen B
Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems.
Cunha S; Amaral MH; Lobo JM; Silva AC
Curr Med Chem; 2016; 23(31):3618-3631. PubMed ID: 27554805
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases.
Nguyen-Thi PT; Ho TT; Nguyen TT; Vo GV
Curr Drug Deliv; 2024; 21(7):917-931. PubMed ID: 37424345
[TBL] [Abstract][Full Text] [Related]
6. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
Wakaskar RR
J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
Narang AS; Chang RK; Hussain MA
J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
[TBL] [Abstract][Full Text] [Related]
8. Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations.
Zorkina Y; Abramova O; Ushakova V; Morozova A; Zubkov E; Valikhov M; Melnikov P; Majouga A; Chekhonin V
Molecules; 2020 Nov; 25(22):. PubMed ID: 33202839
[TBL] [Abstract][Full Text] [Related]
9. Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery.
Huynh L; Neale C; Pomès R; Allen C
Nanomedicine; 2012 Jan; 8(1):20-36. PubMed ID: 21669300
[TBL] [Abstract][Full Text] [Related]
10. Dendronized Systems for the Delivery of Chemotherapeutics.
Dockery L; Daniel MC
Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
[TBL] [Abstract][Full Text] [Related]
11. Polymer- and liposome-based nanoparticles in targeted drug delivery.
Venkatraman SS; Ma LL; Natarajan JV; Chattopadhyay S
Front Biosci (Schol Ed); 2010 Jun; 2(3):801-14. PubMed ID: 20515826
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology and Alzheimer's disease: what has been done and what to do.
Ruozi B; Belletti D; Pederzoli F; Veratti P; Forni F; Vandelli MA; Tosi G
Curr Med Chem; 2014; 21(36):4169-85. PubMed ID: 25039777
[TBL] [Abstract][Full Text] [Related]
13. Progress in antiretroviral drug delivery using nanotechnology.
Mallipeddi R; Rohan LC
Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Fonseca-Santos B; Gremião MP; Chorilli M
Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
16. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
17. Rapid delivery of drug carriers propelled and navigated by catalytic nanoshuttles.
Kagan D; Laocharoensuk R; Zimmerman M; Clawson C; Balasubramanian S; Kang D; Bishop D; Sattayasamitsathit S; Zhang L; Wang J
Small; 2010 Dec; 6(23):2741-7. PubMed ID: 20979242
[TBL] [Abstract][Full Text] [Related]
18. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
Rajpoot K
Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
[TBL] [Abstract][Full Text] [Related]
19. Nano-formulations of drugs: Recent developments, impact and challenges.
Jeevanandam J; Chan YS; Danquah MK
Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]